Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Department of Physiology, Anatomy & Genetics (DPAG) Postdoctoral Research Scientist Dr Sophia Malandraki-Miller took part in a pilot careers mentoring session at Oxford High School. This exciting new engagement programme is a collaboration between Medical Sciences Division researchers and Oxford Biomedical Research Centre and aims to increase awareness of the variety of careers in biomedicine.

Dr Sophia Malandraki-Miller, Postdoctoral Research Scientist in the Riley Group (DPAG) took part in a valuable new careers mentoring opportunity piloted in collaboration between the Medical Sciences Division's Next Generation Leaders Programme and Oxford Biomedical Research Centre (BRC). This exciting new engagement programme links local schools with research and healthcare professionals within the University of Oxford and the Oxford University Hospital NHS Foundation Trust, and aims to increase awareness of the variety of careers in biomedicine.

The pilot session took place at Oxford High School with volunteers each giving around an hour of their time to speak to 15-year-old students looking at the next steps in their academic careers. Students gathered around different tables in groups of 10, with researchers moving between each group answering questions about their jobs and how they got to where they are. 

Read the full story on the DPAG website

Similar stories

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Investigating New Treatment for Schizophrenia

General Innovation Research

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.